Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2,029 DKK | +1.96% | +0.55% | -6.13% |
May. 03 | GENMAB : A good start to 2024; guidance unchanged | |
May. 03 | Genmab Posts Q1 Net Profit Surge; Revenue Jumps | MT |
ETFs positioned on Genmab A/S
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.64% | 200 M€ | +18.28% | ||
1.28% | 48 M€ | +9.30% | ||
1.01% | 85 M€ | +0.23% | ||
0.75% | 17 M€ | +6.46% | - | |
0.56% | 727 M€ | +8.36% | ||
0.49% | 88 M€ | +10.37% | - | |
0.45% | 25 M€ | +3.50% | - | |
0.33% | 6 M€ | -.--% | - | |
0.33% | 4 M€ | -.--% | - | |
0.32% | 36 M€ | +2.97% | - | |
0.31% | 6 M€ | -.--% | ||
0.29% | 2 M€ | +9.19% | - | |
0.29% | 2 M€ | -.--% | - | |
0.24% | 29 M€ | +8.37% | - | |
0.20% | 7 M€ | +5.02% | - | |
0.19% | 20 M€ | +1.33% | - | |
0.14% | 3,859 M€ | +18.82% | - | |
0.14% | 469 M€ | -2.05% | ||
0.14% | 10 M€ | -3.35% | - | |
0.09% | 276 M€ | +11.40% | - | |
0.08% | 264 M€ | -.--% | - | |
0.08% | 187 M€ | +9.40% | - | |
0.08% | 477 M€ | +11.35% | ||
0.07% | 7 M€ | +0.11% | - | |
0.06% | 0 M€ | 0.00% | - | |
0.04% | 283 M€ | +19.39% | ||
0.04% | 206 M€ | -.--% | ||
0.04% | 1,166 M€ | +0.26% | - | |
0.04% | 607 M€ | +0.05% | - | |
0.04% | 23 M€ | -.--% | - | |
0.04% | 786 M€ | -.--% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.13% | 18.59B | |
+5.50% | 111B | |
+11.17% | 105B | |
-12.26% | 22.34B | |
-3.00% | 21.93B | |
-36.52% | 18.12B | |
-9.51% | 16.96B | |
+2.91% | 13.7B | |
+37.46% | 12.45B | |
+295.97% | 7.98B |
- Stock Market
- Equities
- GMAB Stock
- Funds and ETFs Genmab A/S